Skip to content

Clinical trials

Phase 2 Hereditary Sensory and Autonomic Neuropathies trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hereditary Sensory and Autonomic Neuropathies Phase: Phase 2 Country / region: Canada Clear all

5 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20171
20181
20191
20211
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Active, not recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Actuate Therapeutics Inc.1
AllRock Bio, Inc.1
Incyte Corporation1
Novartis Pharmaceuticals1
Revolution Medicines, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hereditary Sensory and Autonomic Neuropathies5
Breast Neoplasms2
Lung Neoplasms2
Lymphoma, Non-Hodgkin2
Neoplasms2
Bone Neoplasms1
Bronchial Neoplasms1
Carcinoma1
Carcinoma, Non-Small-Cell Lung1
Colorectal Neoplasms1

Trials

Showing 1 to 5 of 5. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.